CRISIL has informed that the Board of Directors of the Company, at their meeting held on 21st July 2022, has approved the Unaudited Standalone and Consolidated Financial Results for the second quarter ended June 30, 2022. A copy of the Unaudited Financial Results of the Company, along with a copy of the Limited Review Report and the Press Release in this regard are enclosed. The Board of Directors has also approved the payment of Interim dividend of Rs 8 per equity share of face value of Re 1 each, for the financial year ending December 31, 2022, which will be paid on August 18, 2022. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors also approved re-appointment of Girish Paranjpe as an Independent Director, for a second term from October 17, 2022 up to October 16, 2027, subject to shareholders approval through a postal ballot. The brief profile of Girish Paranjpe is attached as Annexure A. Girish Paranjpe is not debarred from holding the office of a director by virtue of any SEBI order or any other such authority. Girish Paranjpe has no relationship with any member of the Board of directors. The meeting of the Board of Directors commenced at 5.45 pm IST and today’s proceedings concluded at pm IST.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
CRISIL | 5676.30 |
ICRA | 6187.75 |
Care Ratings | 1324.65 |
View more.. |